NCT05346523

Brief Summary

10 to 35% of patients admitted to an emergency department receive an incorrect diagnosis. Not surprisingly, given the wide variety of health conditions encountered in emergency medicine, physicians often do not consider, remember, or know all possible diagnoses that fit the patient's symptoms. Nowadays, computer software (CDDS) is able to support physicians with a list of possible diagnoses by matching entered patient data to a large database with diagnoses. However, it is still unclear how the use of such a CDDS actually affects the diagnostic quality and workflow in 'real world' ER routine care. Therefore, the aim of this cluster-randomized cross-over trial is to evaluate the consequences of CDDS usage on diagnostic quality, patient outcomes and diagnostic workflow within the ER. Four ER's will provide a CDDS to the diagnosing physicians for specific periods (randomly and alternatingly allocated) in which physicians will be asked to use it for all included study patients. Outcomes between periods with and without the CDDS will be compared. Primary outcome is a diagnostic quality risk score composed of unscheduled ER revisits, unexpected hospitalization (both within 14 days), unexpected intensive medical care unit admission if hospitalized and diagnostic discrepancy between the ER discharge diagnosis and the current diagnosis after 14 days. In total, 1'184 patients will be included.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,218

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jun 2022

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 21, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 26, 2022

Completed
1 month until next milestone

Study Start

First participant enrolled

June 9, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 13, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 13, 2023

Completed
Last Updated

July 21, 2023

Status Verified

July 1, 2023

Enrollment Period

1.1 years

First QC Date

March 21, 2022

Last Update Submit

July 20, 2023

Conditions

Keywords

EmergencyDiagnostic ErrorDiagnostic SafetyMisdiagnosisCDDSComputerized Decision Support SystemDiagnostic Quality

Outcome Measures

Primary Outcomes (1)

  • Diagnostic quality risk score

    Primary endpoint is a binary score indicating a diagnostic quality risk, composed of: * Death within 14 days after emergency room discharge (yes/no) * Unscheduled medical care (emergency room revisits, General Practitioner visits or hospitalization) within 14 days after emergency room discharge (yes/no) * Unexpected intensive care unit admission from ward within 24 hours when hospitalized (yes/no) * Diagnostic discrepancy between the emergency room discharge diagnosis and the current diagnosis 14 days after emergency room discharge (yes/no)

    From emergency room discharge to 14 days after emergency room discharge

Secondary Outcomes (15)

  • Death within 14 days after Emergency Room discharge (yes/no)

    From emergency room discharge to 14 days after emergency room discharge

  • Unexpected intensive care unit admission

    Within 24 hours from emergency room transfer to hospital ward

  • Diagnostic discrepancy

    From emergency room discharge to 14 days after emergency room discharge

  • Unscheduled medical care 72 hours, 7 days and 14 days

    From emergency room discharge to 72 hours, 7 days and 14 days after emergency room discharge

  • Length of emergency room stay

    Time from emergency room admission to emergency room discharge, up to 24 hours

  • +10 more secondary outcomes

Study Arms (2)

Usual Care + CDDS usage

EXPERIMENTAL

Patients presenting to the ER and included in the study during the ER's intervention period will be treated and diagnosed by the ER physicians as usual but with support of the CDDS.

Device: Isabel Pro - The DDx generator (CDDS)

Usual Care

NO INTERVENTION

Patients presenting to the ER and included in the study during the ER's intervention period will be treated and diagnosed by the ER physicians as usual without support of the CDDS.

Interventions

Isabel Pro - the DDx generator is a software developped for health professionals with the intention to support them in broadening their differential diagnoses. After the first patient examination, the resident is asked to enter patient symptoms into Isabel Pro, which returns a list of possible diagnoses from its underlying database that matches the entered data. The diagnosing resident physicians will be asked to consult Isabel Pro at least once within the first hour after the first patient assessement. After entering patient symptoms into the software, Isabel Pro will itself return a list with possible diagnoses derived from their underlying database. It is then free to the physician to decide whether one or more of the suggested DDx should be considered for further diagnostic or treatment procedure based on clinical judgement.

Usual Care + CDDS usage

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Informed Consent signed by the subject
  • Presentation to the ER with fever, abdominal pain, syncope or Non-specific complaint (NSC) as chief complaint
  • Triaged as "not vitally threatened"
  • The study subject is 18 years old or older.

You may not qualify if:

  • Trauma as chief complaint
  • Pregnancy
  • Worsening of a known pre-existing condition or medical referral with a definite diagnosis
  • Inability to follow the informed consent and investigation procedures
  • Previous enrolment into the current investigation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Dept. of internal and emergency medicine, Spital Münsigen

Münsingen, Canton of Bern, 3110, Switzerland

Location

Dept. of Internal and Emergency Medicine, Spital Tiefenau

Bern, 3004, Switzerland

Location

Dept. of Emergency Medicine, Inselspital, University Hospital Bern

Bern, 3010, Switzerland

Location

Dept. of Internal and Emergency Medicine, Buergerspital Solothurn

Solothurn, 3004, Switzerland

Location

Related Publications (2)

  • Hautz WE, Marcin T, Hautz SC, Schauber SK, Krummrey G, Muller M, Sauter TC, Lambrigger C, Schwappach D, Nendaz M, Lindner G, Bosbach S, Griesshammer I, Schonberg P, Pluss E, Romann V, Ravioli S, Werthmuller N, Kolbener F, Exadaktylos AK, Singh H, Zwaan L. Diagnoses supported by a computerised diagnostic decision support system versus conventional diagnoses in emergency patients (DDX-BRO): a multicentre, multiple-period, double-blind, cluster-randomised, crossover superiority trial. Lancet Digit Health. 2025 Feb;7(2):e136-e144. doi: 10.1016/S2589-7500(24)00250-4.

  • Marcin T, Hautz SC, Singh H, Zwaan L, Schwappach D, Krummrey G, Schauber SK, Nendaz M, Exadaktylos AK, Muller M, Lambrigger C, Sauter TC, Lindner G, Bosbach S, Griesshammer I, Hautz WE. Effects of a computerised diagnostic decision support tool on diagnostic quality in emergency departments: study protocol of the DDx-BRO multicentre cluster randomised cross-over trial. BMJ Open. 2023 Mar 29;13(3):e072649. doi: 10.1136/bmjopen-2023-072649.

MeSH Terms

Conditions

Emergencies

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Wolf Hautz, Prof. MD

    Prof. MD

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
DIAGNOSTIC
Intervention Model
CROSSOVER
Model Details: Cluster-Randomized Cross-Over Trial
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 21, 2022

First Posted

April 26, 2022

Study Start

June 9, 2022

Primary Completion

July 13, 2023

Study Completion

July 13, 2023

Last Updated

July 21, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will share

Researchers who wish to use IPD for a nested study need to submit a proposal to the Sponsor-Investigator and request permission. A concept sheet describing the planned analyses must be approved by the sponsor-investigator and PIs of the participating sites. Nested studies might need separate ethics permission.

Locations